 Bradford Siegele
Concepts (142)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Burkitt Lymphoma | 2 | 2022 | 62 | 0.870 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2024 | 293 | 0.610 |
Why?
| | Sarcoma | 2 | 2025 | 205 | 0.600 |
Why?
| | Leukemia, Hairy Cell | 1 | 2018 | 7 | 0.570 |
Why?
| | Pancytopenia | 1 | 2018 | 7 | 0.570 |
Why?
| | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2024 | 89 | 0.550 |
Why?
| | Biomarkers, Tumor | 3 | 2026 | 1322 | 0.480 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2017 | 211 | 0.440 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 5 | 2024 | 1958 | 0.420 |
Why?
| | Small Cell Lung Carcinoma | 1 | 2016 | 119 | 0.420 |
Why?
| | Immunohistochemistry | 5 | 2022 | 1718 | 0.390 |
Why?
| | Homeodomain Proteins | 1 | 2017 | 524 | 0.380 |
Why?
| | Carcinoma, Squamous Cell | 3 | 2022 | 642 | 0.380 |
Why?
| | ErbB Receptors | 1 | 2016 | 629 | 0.370 |
Why?
| | Mutation | 3 | 2025 | 4099 | 0.330 |
Why?
| | Leukemia, Myeloid, Acute | 3 | 2024 | 683 | 0.310 |
Why?
| | Mouth Neoplasms | 2 | 2025 | 90 | 0.290 |
Why?
| | Head and Neck Neoplasms | 2 | 2018 | 562 | 0.290 |
Why?
| | Eukaryotic Initiation Factor-4E | 1 | 2008 | 32 | 0.280 |
Why?
| | Splenosis | 1 | 2026 | 2 | 0.250 |
Why?
| | Diagnosis, Differential | 4 | 2018 | 1495 | 0.240 |
Why?
| | Lymphoma, T-Cell, Peripheral | 1 | 2026 | 20 | 0.240 |
Why?
| | SMARCB1 Protein | 1 | 2026 | 34 | 0.240 |
Why?
| | Neoplasm, Residual | 2 | 2024 | 139 | 0.230 |
Why?
| | Gene Rearrangement | 2 | 2024 | 155 | 0.230 |
Why?
| | Genetic Therapy | 1 | 2008 | 313 | 0.230 |
Why?
| | Nephrotic Syndrome | 1 | 2026 | 44 | 0.230 |
Why?
| | Azacitidine | 2 | 2024 | 157 | 0.230 |
Why?
| | Neoplasm Metastasis | 1 | 2008 | 695 | 0.220 |
Why?
| | Papilloma | 1 | 2025 | 49 | 0.220 |
Why?
| | Erythroblasts | 1 | 2025 | 19 | 0.220 |
Why?
| | Podocytes | 1 | 2026 | 80 | 0.220 |
Why?
| | Oropharyngeal Neoplasms | 1 | 2025 | 55 | 0.220 |
Why?
| | Immunophenotyping | 2 | 2025 | 322 | 0.210 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 2 | 2024 | 280 | 0.210 |
Why?
| | Myeloid-Lymphoid Leukemia Protein | 1 | 2024 | 72 | 0.190 |
Why?
| | Membrane Glycoproteins | 1 | 2026 | 496 | 0.190 |
Why?
| | Carcinoma, Mucoepidermoid | 1 | 2022 | 17 | 0.190 |
Why?
| | Sulfonamides | 2 | 2024 | 581 | 0.190 |
Why?
| | Lung Neoplasms | 1 | 2016 | 2642 | 0.180 |
Why?
| | Salivary Gland Neoplasms | 1 | 2022 | 39 | 0.180 |
Why?
| | Gene Fusion | 1 | 2022 | 29 | 0.180 |
Why?
| | Histone-Lysine N-Methyltransferase | 1 | 2024 | 141 | 0.180 |
Why?
| | Translocation, Genetic | 2 | 2022 | 118 | 0.180 |
Why?
| | Lymphoproliferative Disorders | 1 | 2022 | 57 | 0.180 |
Why?
| | Papillomavirus Infections | 1 | 2025 | 345 | 0.160 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2022 | 101 | 0.160 |
Why?
| | Lymphoma, Large B-Cell, Diffuse | 1 | 2022 | 192 | 0.150 |
Why?
| | Endothelial Cells | 1 | 2026 | 870 | 0.150 |
Why?
| | Child | 8 | 2026 | 22657 | 0.150 |
Why?
| | Organ Transplantation | 1 | 2022 | 248 | 0.140 |
Why?
| | Lymphadenopathy | 1 | 2018 | 8 | 0.140 |
Why?
| | Epistaxis | 1 | 2018 | 17 | 0.140 |
Why?
| | Humans | 21 | 2026 | 144957 | 0.140 |
Why?
| | Erythema | 1 | 2018 | 28 | 0.140 |
Why?
| | Young Adult | 5 | 2026 | 14126 | 0.140 |
Why?
| | Adolescent | 7 | 2026 | 22453 | 0.140 |
Why?
| | Fusion Proteins, bcr-abl | 1 | 2018 | 69 | 0.140 |
Why?
| | Male | 14 | 2026 | 72406 | 0.140 |
Why?
| | Forearm | 1 | 2018 | 140 | 0.140 |
Why?
| | Myelodysplastic Syndromes | 1 | 2019 | 147 | 0.130 |
Why?
| | Parotid Gland | 1 | 2017 | 17 | 0.130 |
Why?
| | Parotid Neoplasms | 1 | 2017 | 15 | 0.130 |
Why?
| | Liver | 1 | 2026 | 1888 | 0.130 |
Why?
| | Clinical Laboratory Techniques | 1 | 2018 | 96 | 0.130 |
Why?
| | Combined Modality Therapy | 2 | 2019 | 1268 | 0.130 |
Why?
| | Cadherins | 1 | 2018 | 201 | 0.120 |
Why?
| | Cysts | 1 | 2017 | 111 | 0.120 |
Why?
| | Neck | 1 | 2017 | 108 | 0.120 |
Why?
| | Spleen | 1 | 2018 | 508 | 0.120 |
Why?
| | Phosphoproteins | 1 | 2018 | 346 | 0.120 |
Why?
| | Teratoma | 1 | 2017 | 120 | 0.120 |
Why?
| | Lymphoma | 1 | 2017 | 233 | 0.120 |
Why?
| | Codon | 1 | 2016 | 94 | 0.120 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2018 | 428 | 0.110 |
Why?
| | Fatal Outcome | 1 | 2016 | 307 | 0.110 |
Why?
| | Positron Emission Tomography Computed Tomography | 1 | 2016 | 117 | 0.110 |
Why?
| | Amino Acid Substitution | 1 | 2016 | 304 | 0.110 |
Why?
| | Aged, 80 and over | 4 | 2025 | 8279 | 0.110 |
Why?
| | DNA Mutational Analysis | 1 | 2016 | 409 | 0.110 |
Why?
| | Ultrasonography | 1 | 2018 | 770 | 0.110 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2019 | 676 | 0.100 |
Why?
| | Female | 11 | 2026 | 78376 | 0.100 |
Why?
| | Pain | 1 | 2018 | 782 | 0.090 |
Why?
| | Biopsy | 1 | 2016 | 1077 | 0.090 |
Why?
| | Treatment Outcome | 4 | 2024 | 11695 | 0.090 |
Why?
| | Sensitivity and Specificity | 1 | 2017 | 1990 | 0.090 |
Why?
| | Tomography, X-Ray Computed | 2 | 2018 | 2738 | 0.080 |
Why?
| | Adult | 6 | 2026 | 40506 | 0.080 |
Why?
| | Child, Preschool | 4 | 2026 | 11799 | 0.070 |
Why?
| | Genes, Transgenic, Suicide | 1 | 2008 | 7 | 0.070 |
Why?
| | Prognosis | 3 | 2024 | 4293 | 0.070 |
Why?
| | Mice, Inbred C3H | 1 | 2008 | 251 | 0.070 |
Why?
| | Magnetic Resonance Imaging | 2 | 2017 | 3869 | 0.070 |
Why?
| | Neoplasms, Experimental | 1 | 2008 | 173 | 0.060 |
Why?
| | Aged | 4 | 2025 | 25947 | 0.060 |
Why?
| | Middle Aged | 6 | 2026 | 35928 | 0.060 |
Why?
| | Genetic Vectors | 1 | 2008 | 337 | 0.060 |
Why?
| | Splenectomy | 1 | 2026 | 65 | 0.060 |
Why?
| | Disease-Free Survival | 1 | 2008 | 769 | 0.060 |
Why?
| | Integrin beta1 | 1 | 2026 | 33 | 0.060 |
Why?
| | Proteinuria | 1 | 2026 | 102 | 0.060 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2026 | 132 | 0.060 |
Why?
| | Receptors, Complement | 1 | 2026 | 125 | 0.060 |
Why?
| | Kidney Glomerulus | 1 | 2026 | 128 | 0.060 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2026 | 178 | 0.050 |
Why?
| | Papillomaviridae | 1 | 2025 | 115 | 0.050 |
Why?
| | Retrospective Studies | 4 | 2025 | 17101 | 0.050 |
Why?
| | Transcription Factors | 2 | 2026 | 1742 | 0.050 |
Why?
| | Doxorubicin | 1 | 2026 | 397 | 0.050 |
Why?
| | Infant | 3 | 2025 | 10039 | 0.050 |
Why?
| | Antigens, CD20 | 1 | 2022 | 35 | 0.050 |
Why?
| | Chromosome Aberrations | 1 | 2022 | 163 | 0.040 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2022 | 323 | 0.040 |
Why?
| | Polymerase Chain Reaction | 1 | 2024 | 1054 | 0.040 |
Why?
| | Rituximab | 1 | 2022 | 210 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2022 | 167 | 0.040 |
Why?
| | Trans-Activators | 1 | 2022 | 405 | 0.040 |
Why?
| | Follow-Up Studies | 2 | 2019 | 5417 | 0.040 |
Why?
| | Cell Line, Tumor | 1 | 2008 | 3550 | 0.040 |
Why?
| | Mice | 2 | 2026 | 18365 | 0.040 |
Why?
| | Signal Transduction | 2 | 2026 | 5233 | 0.040 |
Why?
| | Remission Induction | 1 | 2019 | 308 | 0.040 |
Why?
| | DNA-Binding Proteins | 1 | 2026 | 1500 | 0.040 |
Why?
| | Mice, Knockout | 1 | 2026 | 3125 | 0.040 |
Why?
| | Hepatocyte Growth Factor | 1 | 2018 | 33 | 0.040 |
Why?
| | Phenotype | 1 | 2026 | 3164 | 0.030 |
Why?
| | Biopsy, Fine-Needle | 1 | 2017 | 68 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2018 | 336 | 0.030 |
Why?
| | Genetic Testing | 1 | 2019 | 482 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2018 | 744 | 0.030 |
Why?
| | Proto-Oncogene Proteins | 1 | 2018 | 623 | 0.030 |
Why?
| | Survival Rate | 1 | 2019 | 2092 | 0.030 |
Why?
| | Animals | 2 | 2026 | 38109 | 0.030 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2017 | 1141 | 0.020 |
Why?
| | Mouth Mucosa | 1 | 2011 | 88 | 0.020 |
Why?
| | Cell Separation | 1 | 2011 | 307 | 0.020 |
Why?
| | Keratinocytes | 1 | 2011 | 250 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2019 | 6434 | 0.020 |
Why?
| | Stem Cells | 1 | 2011 | 627 | 0.010 |
Why?
| | Epithelial Cells | 1 | 2011 | 1126 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2011 | 4155 | 0.010 |
Why?
|
|
Siegele's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|